Meeting of Ebola Experimental Interventions: Scientific and Technical Advisory Committee

Meeting of Ebola Experimental Interventions: Scientific and Technical Advisory Committee

20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Meeting of Ebola Experimental Interventions: Scientific and Technical Advisory Committee
11-12 November 2014
Salle C, WHO headquarters, Geneva, Switzerland
Provisional List of Participants
Participants
Diallo A. Ahmadou, Responsablee du service Recherche, Membre Commission recherche sur
Ebola, Ministère de la Santé, Conakry, Guinea
Annick Antierens, Medical Department, Médecins Sans Frontières, 78, rue de Lausanne, Geneva,
Switzerland
Sylvain Baize, Head Lab, UBIVE, Centre international de Recherche en Infectiologie, Institut
Pasteur, Lyon, France
Daniel G. Bausch, Head, Virology and Emerging Infections Department, U.S. Naval Medical
Research Unit No.6, Lima, Peru
Sina Bavari, Chief, Science Director, United States Army Medical Research Institute of
Infectious Diseases, Fort Detrick, Maryland, United States of America
Krishnan Bhaskaran, Senior Lecturer in Statistical Epidemiology London School of Hygiene &
Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom of Great Britain &
Northern Ireland
Fred Binka, Dean, School of Public Health, University of Ghana, P.O Box LG581, Legon,
Ghana
Luciana Borio, Assistant Commissioner for Counterterrorism Policy, Acting Deputy Chief
Scientist, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, WO1, Room 4340,
Silver Spring, MD 20993, United States of America
David Brett-Major, Medical Officer, Naval Medical Research Center, Route de Saint Loup 41
1290 Versoix, Switzerland
Marco Cavaleri, Anti-infectives & Vaccines, Human Medicines Evaluation Division, European
Medicines Agency, Canary Wharf, London E14 5EU, United Kingdom of Great Britain &
Northern Ireland (via teleconference)
Matthew Chambers, Chief, Field Studies, United States Army Medical Research Institute of
Infectious Diseases, Fort Detrick, Maryland, United States of America
1
Jennifer Cohn, Medical Coordinator, MSF/Médecins Sans Frontières - Access Campaign, 78, rue
de Lausanne, CP 116 1211 Genève 21, Switzerland
Edward Cox, Director, Food and Drug Administration, Office of Medical Products and Tobacco,
Center for Drug Evaluation and Research, Office of New Drugs, Office of Antimicrobial Products
Silver Spring, MD 20993, United States of America
Iza Ciglenecki, Medecins Sans Frontieres, 78, rue de Lausanne, CP 116 1211 Genève 21,
Switzerland
Peter Dull, Deputy Director, Vaccine Development, Bill and Melinda Gates Foundation, Seattle,
WA 98119, United States of America
Matthias Egger, Institute of Social and Preventive Medicine (ISPM), University of Bern,
Finkenhubelweg 11, Bern 3012, Switzerland
Arnaud Fontanet, Head of the Epidemiology of Emerging Diseases Unit, Institut Pasteur, Paris,
France
Harriet Forbes, Research Fellow, Department of Non-communicable Disease Epidemiology
London School of Hygiene, & Tropical Medicine, Keppel Street, London WC1E 7HT, United
Kingdom of Great Britain & Northern Ireland
Robert Fowler, Senior Scientist, Sunnybrook Health Sciences Centre, 2075 Bayview Ave.,
Toronto, ON M4N 3M5, Canada
Thomas Geisbert, Professor, Microbiology & Immunology, The University of Texas Medical
Branch, Institute for Human Infections & Immunity, Galveston National Laboratory, Galveston,
TX. 77555-0610, United States of America
Armando Genazzani, Head, Genazzani Lab, Via Giovanni Bovio 6, 28100 Novara (NO)
Italy
Rebecca Grais, Director, Epidemiology and Population Health, EPICENTRE, MSF, 8 rue Saint
Sabin, 75011 Paris, France
Stephan Günther, Department of Virology, Bernhard Nocht Institute for Tropical Medicine,
Bernhard-Nocht-Street 74, 20359 Hamburg, Germany
Frederick Hayden, Professor of Clinical Virology, Division of Infectious Diseases and
International Health, University of Virginia School of Medicine, Charlottesville, VA 22908,
United States of America
Lisa E. Hensley, Associate Director of Science, Office of the Chief Scientist, National Institute of
Allergy and Infectious Disease, Integrated Research Facility, Frederick MD 21702, United States
of America
20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Elizabeth Higgs, Global Health Science Advisor, Division of Clinical Research National Institute
of Allergy and Infectious Diseases, United States of America
Peter Horby, Epidemic diseases Research Group (ERGO), Centre for Tropical Medicine
University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, United Kingdom of Great Britain &
Northern Ireland
David Hoover, Program Director, Clinical Research Management, 1265 Ridge Road Ste
Hinckley, OH 44233, United States of America(via teleconference)
David Houeto, Coordinator, Master in Health Promotion Program, School of Public Health
University of Parakou, Benin
Michael Jacobs, Consultant & Hon. Senior Lecturer Infectious Diseases, Royal Free London
NHS Foundation Trust, Pond Street, London NW3 2QG, United Kingdom of Great Britain &
Northern Ireland
Steven Kern, Deputy Director, Quantitative Sciences, Global Health – Integrated Development
Bill and Melinda Gates Foundation, 440 5th Ave N. Seattle, WA 98109, United States of
America
Mandy Kader Konde, Director of Center of excellence for Training & Research on Malaria and
Priority Disease in Guinea (CEFORPAG), Chairman of the Guinea Ebola Research Commission,
Conakry, Guinea
Maria Klimathianaki, European Commission, DG Research & Innovation, Unit H3 - Fighting
Infectious Diseases and Global Epidemics, 1049 Brussels, Belgium
Gary Kobinger, Public Health Agency of Canada, National Microbiology Laboratory, 1015
Arlington Street, Winnipeg Manitoba R3E 3R2, Canada (unable to attend)
Michael G. Kurilla, Chair, Director, Office of Biodefense Research Resources and Translational
Research, National Institute of Allergy and Infectious Diseases, United States of America
Elena Kwon, Deputy Chief, Field Studies, United States Army Medical Research Institute of
Infectious Diseases, Fort Detrick, Maryland, United States of America
Denis Malvy, Centre Hospitalier Universitaire de Bordeaux, Rue Francisco Ferrer 33000
Bordeaux, France
Patricio V. Marquez, Lead Health Specialist, Public Health Focal Point, Health, Nutrition and
Population Global Practice, The World Bank, Washington, D.C., United States of America
Laura Merson, Head of Clinical Trials Unit, Oxford University Clinical Research Unit,
3
National Hospital for Tropical Diseases, 78 Giai Phong Street, Hanoi, Viet Nam
Robert Newman, Managing Director, Policy and Performance, Gavi The Vaccine Alliance, 2
Chemin des Mines, 1202 Geneva, Switzerland
Piero Olliaro, Newton-Abraham Visiting Professor, Fellow of Lincoln College
Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford
United Kingdom of Great Britain & Northern Ireland
Tomoya Saito, Chief Senior Researcher, Department of Health Crisis Management, National
Institute of Public Health, Japan, 2-3-6 Minami, Wako-Shi, Saitama 351-0197, Japan
Amadou Alpha Sall, Institut Pasteur de Dakar, 36, Avenue Pasteur, BP 220 Dakar Senegal
Malcolm Semple, Senior Lecturer in Child Health, Consultant Respiratory Paediatrician
Institute of Child Health, University of Liverpool, Liverpool, L12 2AP, United Kingdom of
Great Britain & Northern Ireland
Micaela Serafini, Medical Director, Medecins Sans Frontieres, 78, rue de Lausanne, CP 116 1211
Genève 21, Switzerland
Haleema Shakur, Senior Lecturer, Co-Director, Clinical Trials Unit, Faculty of Epidemiology
and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London
WC1E 7HT, United Kingdom of Great Britain & Northern Ireland
Christina Spiropoulou, Division of High Consequence Pathogens and Pathology, National
Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention,
Atlanta, United States of America
Els Torreele, Director, Access to Essential Medicines Initiative, Public Health Program, Open
Society Foundations, New York 10019, United States of America (via teleconference)
Ross Upshur, Head, Division of Clinical Public Health Dalla Lana School of Public Health
University of Toronto, Toronto, Ontario M5S 2J7, Canada (unable to attend)
Pauline Vetter, Laboratory of Virology, Division of Infectious Diseases and Division of
Laboratory Medicine, Hôpitaux Universitaires de Genève, 1205 Genève, Switzerland
Robert Walker, Deputy Director, Division of Clinical Studies, Biomedical Advanced Research
and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US
Department of Health and Human Services, Washington, DC 20024, United States of America
Timo Wolf, Senior Physician, Specialist in Internal Medicine and Infectious Diseases, University
Hospital Frankfurt, HIVCENTER Department of Medicine II Infectious Diseases Unit, Theodor
Stern Kai 7, 60590 Frankfurt, Germany
20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Yazdan Yazdanpanah, Infectious Disease department Bichat Hospital, Assistance PubliqueHôpitaux de Paris/Inserm, 3, avenue Victoria 75004 Paris, France
Kathryn C. Zoon, Director, Division of Intramural Research, Chief, Cytokine Biology Section,
National Institute of Allergy and Infectious Diseases, United States of America (via
teleconference)
WHO Regional Office
Dina Pfeifer, Programme Manager, Vaccine Preventable Diseases and Immunization, WHO
Regional Office for Europe, UN City Marmorvej 51, DK-2100 Copenhagen Denmark
WHO Secretariat
Neelam Dhingra-Kumar, Coordinator, Patient Safety and Quality Improvement, World Health
Organization, Geneva, Switzerland
Martin Friede, Scientist, Technology Transfer Initiative, Heath Systems and Innovation, World
Health Organization, Geneva, Switzerland
Grace Theo, Technical Officer, Ebola Virus Outbreaks 2014, Heath Systems and Innovation,
World Health Organization, Geneva, Switzerland
Ana Maria Henao-Restrepo, Group Leader, Implementation Research and Economic Analysis,
Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
Marie-Paule Kieny, Assistant Director General, Health Systems and Innovation, World Health
Organization, Geneva, Switzerland
Nicola Magrini, Scientist, Policy, Access and Use, World Health Organization, Geneva,
Switzerland
Asiya I. A. Odugleh-Kolev, Technical Officer, Capacity Assessment, Development &
Maintenance, World Health Organization, Geneva, Switzerland
Cathy Ellen Roth, Advisor, Office of the Assistant Director-General, Heath Systems and
Innovation, World Health Organization, Geneva, Switzerland
Nahoko Shindo, Medical Officer, Infection Control and Publications, World Health Organization,
Geneva, Switzerland
Adriana Velazquez, Senior Adviser, Policy, Access and Use, World Health Organization,
Geneva, Switzerland
5
David Wood, Coordinator, Technologies Standards and Norms, World Health Organization,
Geneva, Switzerland